Yvonne Betancourt

Financial Reporting Manager at AnaptysBio - San Diego, CA, US

Yvonne Betancourt's Colleagues at AnaptysBio
Elisa Lanni

Senior Clinical Study Manager

Contact Elisa Lanni

Eric Hare

Senior Manager, Flow Cytometry

Contact Eric Hare

Lorenzo Tano

Analytical Development Manager

Contact Lorenzo Tano

Joe Sheffer

Senior Program Manager, CMC

Contact Joe Sheffer

Bao Ly

Desktop Support Specialist

Contact Bao Ly

Traci Savall

Senior Manager, CMC Project Management

Contact Traci Savall

View All Yvonne Betancourt's Colleagues
Yvonne Betancourt's Contact Details
HQ
858-362-6295
Location
Company
AnaptysBio
Yvonne Betancourt's Company Details
AnaptysBio logo, AnaptysBio contact details

AnaptysBio

San Diego, CA, US • 100 - 249 Employees
BioTech/Drugs

AnaptysBio is a clinical-stage antibody development company advancing therapeutic antibody product candidates focused on unmet medical needs in inflammation. We develop our product candidates to address emerging biological targets using our proprietary antibody discovery technology platform, which is based upon a breakthrough understanding of the natural process of antibody generation, known as somatic hypermutation, or SHM, and replicates this natural process of antibody generation in vitro. Our strategy is to advance the development and commercialization of our proprietary product candidates, and for certain programs, establish partnerships with leading biopharmaceutical companies where we retain certain development and commercialization rights in the United States.Our wholly-owned product pipeline includes etokimab (ANB020) and ANB019, which are being developed to treat severe inflammatory disorders with unmet medical need. We are advancing etokimab, an antibody that inhibits the activity of interleukin-33, for the treatment of moderate-to-severe adult atopic dermatitis, severe adult eosinophilic asthma, and adult chronic rhinosinusitis with nasal polyps (CRSwNP).In addition, we are developing our ANB019 product candidate, an antibody that inhibits the interleukin-36 receptor, for the treatment of rare inflammatory diseases called generalized pustular psoriasis (GPP) and palmoplantar pustulosis (PPP).Our company is led by a strong management team with a proven track record of successfully growing biotechnology companies with deep experience in antibody discovery and development, collaborations, operations and corporate finance.Additionally, multiple AnaptysBio-generated antibodies have entered the clinic under our immuno-oncology-focused collaboration with TESARO and inflammation-focused collaboration with Celgene.For more information, visit www.anaptysbio.com.

Antibodies Cancer immunotherapy Inflammation Fibrosis Immunology Biotech SaaS Commercial Physical Research Biotechnology Biotech Pharmaceuticals
Details about AnaptysBio
Frequently Asked Questions about Yvonne Betancourt
Yvonne Betancourt currently works for AnaptysBio.
Yvonne Betancourt's role at AnaptysBio is Financial Reporting Manager.
Yvonne Betancourt's email address is ***@anaptysbio.com. To view Yvonne Betancourt's full email address, please signup to ConnectPlex.
Yvonne Betancourt works in the Biotechnology industry.
Yvonne Betancourt's colleagues at AnaptysBio are Elisa Lanni, Nick Almaguer, Eric Hare, Lorenzo Tano, Joe Sheffer, Bao Ly, Traci Savall and others.
Yvonne Betancourt's phone number is 858-362-6295
See more information about Yvonne Betancourt